Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.014 USD | +40.00% | +40.00% | +28.44% |
Jun. 01 | Medivolve Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 02 | Medivolve Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Financials (USD)
Sales 2022 | 37.18 | Sales 2023 | 0.69 | Capitalization | 390K |
---|---|---|---|---|---|
Net income 2022 | -18M | Net income 2023 | -16M | EV / Sales 2022 | 22,108 x |
Net cash position 2022 | 2.64M | Net Debt 2023 | 665K | EV / Sales 2023 | 1,537,011 x |
P/E ratio 2022 |
-0.19
x | P/E ratio 2023 |
-0.02
x | Employees | 25 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 94.14% |
1 day | +40.00% | ||
1 week | +40.00% | ||
1 month | +100.00% | ||
3 months | +40.00% | ||
6 months | -27.46% | ||
Current year | +28.44% |
Managers | Title | Age | Since |
---|---|---|---|
David Preiner
CEO | Chief Executive Officer | - | 21-04-29 |
Evan Veryard
IRC | Investor Relations Contact | - | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-10 | 0.014 | +40.00% | 1,380 |
24-06-07 | 0.01 | 0.00% | 51,758 |
24-06-05 | 0.01 | +100.00% | 3,000 |
24-06-04 | 0.005 | -50.00% | 170,025 |
Delayed Quote OTC Markets, June 10, 2024 at 01:57 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+28.44% | 378K | |
+33.63% | 8.68B | |
+40.24% | 4.56B | |
-28.19% | 2.72B | |
-8.96% | 1.61B | |
-22.22% | 1.34B | |
-37.12% | 1.08B | |
+3.82% | 929M | |
-43.36% | 791M | |
-21.97% | 675M |
- Stock Market
- Equities
- MEDVF Stock